Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTL
about
Immunogenicity of recombinant classic swine fever virus CD8(+) T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccinationProtection against Foot-and-Mouth Disease Virus in Guinea Pigs via Oral Administration of Recombinant Lactobacillus plantarum Expressing VP1.Developing recombinant and synthetic vaccines for the treatment of melanoma.The new vaccines: building viruses that elicit antitumor immunity.Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model.Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccineEvaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanomaDe novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model.Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses.The next wave of recombinant and synthetic anticancer vaccines.Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancerDendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitroAnthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo.
P2860
Q35530213-18FB14D5-B535-4C7E-86F6-665AC91B3B58Q35858585-02CF4ED9-D220-4286-A1E4-E241FCBEBC88Q35946196-AA8B075A-46CD-4720-A4B2-213E7EE281ADQ35946203-41F8F773-99FC-4012-9CD7-9FFF320A8898Q35946213-8A4008C8-BEEF-4D17-8604-4AC478F163F6Q36082419-8A40EEFA-8DBF-4354-AE82-314EFB636E80Q36294815-288D87AD-6156-438C-B99E-39D87795A3F3Q36459332-3B5F0C03-D78F-4A8B-B2C7-A1CA75178996Q36470715-F55F8653-0C0A-491E-B337-73A4256AC7E8Q36470749-C17315E9-ABEA-459A-B34D-28F89C779D51Q36659320-F4E78D29-A0A2-45CA-BFE0-6523612834C9Q36916492-B5B02B10-45C7-4C9C-B884-C1E9408DA77FQ36924579-84197E91-09CF-4906-9AFF-6888D07D7B35Q37242580-7FB1B619-CB23-4751-AA76-CA398E3CB4B2
P2860
Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTL
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Synthetic oligonucleotide expr ...... virus elicits therapeutic CTL
@ast
Synthetic oligonucleotide expr ...... virus elicits therapeutic CTL
@en
Synthetic oligonucleotide expr ...... virus elicits therapeutic CTL
@nl
type
label
Synthetic oligonucleotide expr ...... virus elicits therapeutic CTL
@ast
Synthetic oligonucleotide expr ...... virus elicits therapeutic CTL
@en
Synthetic oligonucleotide expr ...... virus elicits therapeutic CTL
@nl
prefLabel
Synthetic oligonucleotide expr ...... virus elicits therapeutic CTL
@ast
Synthetic oligonucleotide expr ...... virus elicits therapeutic CTL
@en
Synthetic oligonucleotide expr ...... virus elicits therapeutic CTL
@nl
P2093
P2860
P1476
Synthetic oligonucleotide expr ...... virus elicits therapeutic CTL
@en
P2093
B J McCabe
K R Irvine
N P Restifo
S A Rosenberg
P2860
P304
P407
P577
1995-05-01T00:00:00Z